Bedaquiline-Pretomanid-Linezolid Regimens Compared for XDR TB
FRIDAY, Sept. 16, 2022 (HealthDay News) — For patients with extensively drug-resistant (XDR) tuberculosis, the overall risk-benefit ratio seems to favor patients receiving the bedaquiline-pretomanid-linezolid regimen with linezolid at a dose of 600 m…
Learn MoreAI System Can Detect Pulmonary TB on Chest X-Rays
THURSDAY, Sept. 15, 2022 (HealthDay News) — An artificial intelligence system can detect pulmonary tuberculosis (TB) on chest X-rays with a higher sensitivity than radiologists, according to a study published online Sept. 6 in Radiology.Sahar Kazemza…
Learn MoreMultidose BCG Protects Against COVID-19 in At-Risk Individuals
TUESDAY, Aug. 16, 2022 (HealthDay News) — The multidose Bacillus Calmette-Guerin (BCG) vaccine offers protection against COVID-19 infection among COVID-19-unvaccinated individuals with type 1 diabetes, according to a study published online Aug. 15 …
Learn More